A Study of the Combination Regimen Grazoprevir (MK-5172) and Elbasvir (MK-8742) ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)
Clinical trial NCT01717326 · COMPLETED
Trial details
- NCT number
- NCT01717326
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-07
- Primary completion
- 2015-02-23
- Enrollment
- 573
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.